학술논문
S125: 10-DAY DECITABINE VS. CONVENTIONAL CHEMOTHERAPY ('3 + 7') FOLLOWED BY ALLOGRAFTING (HSCT) IN AML PATIENTS ≥60 YEARS: A RANDOMIZED PHASE III STUDY OF THE EORTC LEUKEMIA GROUP, GIMEMA, CELG, AND GMDS-SG
Document Type
article
Author
M. Lübbert; P. Wijermans; M. Kicinski; S. Chantepie; W. van der Velden; R. Noppeney; L. Griskevicius; A. Neubauer; M. Crysandt; R. Vrhovac; M. Luppi; S. Fuhrmann; E. Audisio; A. Candoni; O. Legrand; R. Foà; G. Gaidano; D. van Lammeren-Venema; E. F. Posthuma; M. Hoogendoorn; A. Giraut; M. Stevens-Kroef; J. H. Jansen; E. Ammatuna; J.-P. Vilque; R. Wäsch; H. Becker; N. Blijlevens; U. Dührsen; F. Baron; S. Suciu; S. Amadori; A. Venditti; G. Huls
Source
HemaSphere, Vol 6, Pp 26-27 (2022)
Subject
Language
English
ISSN
2572-9241